Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 243

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 243
---
 insure our office holders to the maximum extent permitted by law. Our office holders are currently covered by a directors
and officers’ liability insurance policy.

We have entered enter into
agreements with each of our directors and executive officers exculpating them in advance, to the fullest extent permitted by law, from
liability to us for damages caused to us as a result of a breach of duty of care, and undertaking to indemnify them to the fullest extent
permitted by law. This indemnification is limited to events determined as foreseeable by the board of directors based on our activities
and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances.

The maximum indemnification
amount to be set forth in such agreements is limited to an amount equal to the higher of $100 million, 25% of our total shareholders’
equity as reflected in our most recent consolidated financial statements prior to the date on which the indemnity payment is made and
10% of our total market capitalization calculated based on the average closing price of ordinary shares over the 30 trading days prior
to the actual payment, multiplied by the total number of our issued and outstanding shares as of the date of the payment (other than indemnification
for an offering of securities to the public, including by a shareholder in a secondary offering, in which case the maximum indemnification
amount is limited to the gross proceeds raised by us and/or any selling shareholder in such public offering). The maximum amount set forth
in such agreements is in addition to any amount paid (if paid) under insurance and/or by a third-party pursuant to an indemnification
arrangement.

In the opinion of the SEC,
indemnification of directors and office holders for liabilities arising under the Securities Act, however, is against public policy and
therefore unenforceable.

  Employees  
 ─────────────

As of December 31, 2024, we
had 125 FTEs across 3 offices in 4 countries, with 111 FTEs in research and development and related activities.

Of our total number of employees,
112 are located in Israel. We apply the law with respect to all aspects of the employment of our employees including with respect to hiring
and termination procedures, equal opportunity and anti-discrimination laws and other conditions of employment. In many cases, the terms
of employment of our employees exceed the minimum required under Israeli labor laws including, but not limited to, with respect to the
minimum wage,